Calvo E, Doger B, Carles J, Peer A, Sarid D, Eigl B
Oncologist. 2025; 30(1).
PMID: 39832129
PMC: 11745015.
DOI: 10.1093/oncolo/oyae313.
Morizane S, Takenaka A
Prostate Int. 2025; 12(3):117-127.
PMID: 39816936
PMC: 11733762.
DOI: 10.1016/j.prnil.2024.03.002.
Suzuki S, Negoro H, Kubota M, Sumiyoshi T, Saito R, Okuno T
Sci Rep. 2025; 15(1):2025.
PMID: 39815039
PMC: 11736026.
DOI: 10.1038/s41598-025-86521-x.
Kim D, Sonni I, Grogan T, Sisk A, Murthy V, Hsu W
Radiol Imaging Cancer. 2025; 7(1):e240011.
PMID: 39750113
PMC: 11791667.
DOI: 10.1148/rycan.240011.
Zhang T, Li W, Wei H, Huang Z, Yang J, Zeng H
PLoS One. 2024; 19(12):e0307826.
PMID: 39666674
PMC: 11637285.
DOI: 10.1371/journal.pone.0307826.
Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer prognosis.
Larose M, Archambault L, Touma N, Brodeur R, Desroches F, Raymond N
Sci Rep. 2024; 14(1):26928.
PMID: 39505979
PMC: 11541986.
DOI: 10.1038/s41598-024-77498-0.
Risk of anxiety disorders in men with prostate cancer: a national cohort study.
Crump C, Stattin P, Brooks J, Sundquist J, Sundquist K, Sieh W
JNCI Cancer Spectr. 2024; 8(5).
PMID: 39276155
PMC: 11512143.
DOI: 10.1093/jncics/pkae087.
Adaptive approach for tracking movements of biological targets: application to robot-based intervention for prostate cancer.
Smahi A, Lakhal O, Chettibi T, Sanz Lopez M, Pasquier D, Merzouki R
Front Robot AI. 2024; 11:1416662.
PMID: 39188571
PMC: 11345532.
DOI: 10.3389/frobt.2024.1416662.
Management of Advanced Prostate Cancer With Relugolix: Illustrative Case Scenarios From an Advanced Practice Provider Perspective.
Thorley J, Stephen S
J Adv Pract Oncol. 2024; 15(1):43-55.
PMID: 39119081
PMC: 11308532.
DOI: 10.6004/jadpro.2024.15.1.5.
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials.
Spratt D, Liu V, Jia A, Royce T, Sandler H, Pugh S
Eur Urol. 2024; 86(4):369-371.
PMID: 39025748
PMC: 11480946.
DOI: 10.1016/j.eururo.2024.06.019.
Mortality Risks Associated with Depression in Men with Prostate Cancer.
Crump C, Stattin P, Brooks J, Sundquist J, Sieh W, Sundquist K
Eur Urol Oncol. 2024; 7(6):1411-1419.
PMID: 38575410
PMC: 11838044.
DOI: 10.1016/j.euo.2024.03.012.
Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report.
Taverna G, Grizzi F, Bax C, Tidu L, Zanoni M, Vota P
Front Oncol. 2024; 14:1339796.
PMID: 38505583
PMC: 10948417.
DOI: 10.3389/fonc.2024.1339796.
Optical Sensor System for 3D Jones Matrix Reconstruction of Optical Anisotropy Maps of Self-Assembled Polycrystalline Soft Matter Films.
Wojcik W, Hu Z, Ushenko Y, Smolarz A, Soltys I, Dubolazov O
Sensors (Basel). 2024; 24(5).
PMID: 38475128
PMC: 10933998.
DOI: 10.3390/s24051589.
In-Depth Glycoproteomic Assay of Urinary Prostatic Acid Phosphatase.
Wang W, de Nier C, Wuhrer M, Lageveen-Kammeijer G
ACS Meas Sci Au. 2024; 4(1):117-126.
PMID: 38404489
PMC: 10885330.
DOI: 10.1021/acsmeasuresciau.3c00055.
Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires.
Gesztesi L, Kocsis Z, Jorgo K, Frohlich G, Polgar C, Agoston P
Prostate Cancer. 2024; 2024:5729185.
PMID: 38312318
PMC: 10834089.
DOI: 10.1155/2024/5729185.
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.
Nguyen C, Kobe C, Kumbier K, Bauman J, Burns J, Tsao P
JCO Oncol Pract. 2023; 20(1):59-68.
PMID: 38085028
PMC: 10827294.
DOI: 10.1200/OP.23.00258.
Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
Crump C, Stattin P, Brooks J, Sundquist J, Edwards A, Sundquist K
J Natl Cancer Inst. 2023; 116(5):745-752.
PMID: 38060258
PMC: 11077310.
DOI: 10.1093/jnci/djad257.
Clinical practice in prostate PET imaging.
Huls S, Burkett B, Ehman E, Lowe V, Subramaniam R, Kendi A
Ther Adv Med Oncol. 2023; 15:17588359231213618.
PMID: 38028142
PMC: 10666681.
DOI: 10.1177/17588359231213618.
LncRNA LNC-565686 Promotes Proliferation of Prostate Cancer by Inhibiting Apoptosis through Stabilizing SND1.
Qin X, Zhong J, Wang L, Chen Z, Liu X
Biomedicines. 2023; 11(10).
PMID: 37893001
PMC: 10603871.
DOI: 10.3390/biomedicines11102627.
Ethnic differences in prostate cancer presentation: a time for testing advocacy.
Batura D, Patel A, Gandhi A, Pradhan A, Bachoo S, Tetea A
World J Urol. 2023; 41(12):3543-3549.
PMID: 37821779
DOI: 10.1007/s00345-023-04644-0.
